Member Info for johndean

The coronavirus pandemic is "accelerating" and has reached "a new and dangerous phase", according to the World Health Organisation (WHO).

More than 150,000 new cases of the virus were reported to the global health agency on Thursday – the most in a single day so far – WHO chief Tedros Adhanom Ghebreyesus said at a press conference in Geneva on Friday.

"Almost half of those cases were reported from the Americas, with large numbers also being reported from South Asia and the Middle East," he said.

Tedros said the world had now entered "a new and dangerous phase" where most people were fed up with being at home.

De La Rue plc Ordinary 44 152/175p
Type:Open OfferShareholder action required:NoStatus:Effective date: 19th Jun 2020
Details (last updated 19 Jun 2020)
De La Rue plc has announced its intention to raise cash by way of an open offer.

The Open Offer will be available to all Shareholders as at close of business on 16 June 2020. If you hold Shares at this time you will be entitled to purchase 7 new Shares for every 16 Shares held, at a price of 110p per Share. Excess applications will also be allowed.

Entitlements to participate will be issued from Friday 19 June. You need take no action at present. We will write to Qualifying Shareholders confirming full terms of the Open Offer shortly after 19 June 2020, at which point an online election facility will be enabled for qualifying shareholders to give an instruction. Our deadline for the Open Offer is expected to be noon on Wednesday 1 July 2020.

is hemo involved with roche?

F. Hoffmann-La Roche Ltd
Positive phase III results for Venclexta/Venclyxto combination in acute myeloid leukaemia presented at EHA 2020
Phase III VIALE-A study showed Venclexta/Venclyxto plus azacitidine helped people with the most common type of aggressive adult leukaemia live longer compared to azacitidine alone
Data will be presented as a late-breaking abstract at the 25th European Hematology Association Virtual Congress

Basel, 13 June 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive results from the phase III VIALE-A study, evaluating Venclexta®/Venclyxto® (venetoclax) in combination with azacitidine in people with previously untreated acute myeloid leukaemia (AML) who were ineligible for intensive induction chemotherapy. VIALE-A results were featured in the 25th European Hematology Association Virtual Congress Press Briefing on Saturday 13 June 2020 at 08:30 CEST and will be presented at the congress during the Late-breaking Oral Session (abstract #LB2601) on Sunday 14 June 2020.

“We are very pleased to present these important results from people with acute myeloid leukaemia, especially those who are unable to tolerate intensive chemotherapy and therefore have limited treatment options,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “The significant survival benefits observed in the VIALE-A study reinforce the potential utility of this Venclexta/Venclyxto-based combination for people with this aggressive disease.

so now buy is 5.35 and sell is 5.36

Bazza if its 4m then it will take 3 weeks to show and then only as a sell!!

why are they blocking people from buying online
you would think with the fall there would be spare shares around

jp morgan said that in march...old news

Nuformix PLC - pharmaceutical development - Says GBP1.3 million equity fundraise from last year and low operating costs make it "well-placed" to cope with Covid-19 hurt. Notes it may miss out of a GBP2.5 million payment from Chinese partner Newsummit Biopharma, which has fallen out with its own parent company. Teams with New York-listed VistaGen Therapeutics to develop crystalline versions of the latter's central nervous system medication candidates.

cant buy online for a while now

Coronavirus 'disappearing' so fast Oxford vaccine has 'only 50% chance of working'
Professor Adrian Hill describes the efforts to create a vaccine as a "race against the virus disappearing, and against time".
Sunday 24 May 2020 15:49, UK

Telit LM960A18 mPCIe LTE Module Joins the United Kingdom's Emergency Services Network (ESN) Lineup
19/05/2020 2:00pm
PR Newswire (US)

Telit Communications (LSE:TCM)
Intraday Stock Chart

Wednesday 20 May 2020

Click Here for more Telit Communications Charts.
LONDON, May 19, 2020 /PRNewswire/ -- Telit, a global enabler of the Internet of Things (IoT), today announced that its LM960A18 PCI Express Mini Card (mPCIe) is the first Gigabit LTE module to go through the United Kingdom's Emergency Services Network (ESN) review for use by the ecosystem. Joining the ESN lineup is the latest milestone in Telit's commitment to providing the first responder community with solutions and support for potentially lifesaving applications. The LM960A18 is an IoT module that ESN original equipment manufacturers (OEMs), such as handheld devices and wireless routers, can use for gigabit cellular communications.

19/05/2020 5:30pm
PR Newswire (US)

Micro Focus (LSE:MCRO)
Intraday Stock Chart

Wednesday 20 May 2020

Click Here for more Micro Focus Charts.
SANTA CLARA, Calif., May 19, 2020 /PRNewswire/ -- Micro Focus (LSE: MCRO; NYSE: MFGP) today awarded the prestigious Digital Transformation Innovation Award to General Motors (GM) and the Carrefour Group, in recognition of their outstanding efforts leveraging technology in new and inventive ways to respond to emerging market demands, helping them to effectively run and transform their business. The awards will be announced this week at Micro Focus Universe 2020, the company's flagship customer event, being conducted virtually this year due to the current pandemic.

Teva said to ‘walk away’ from settlement talks in US price-fixing lawsuit
Israeli pharmaceutical giant takes a gamble that Trump’s Justice Department won’t file charges after company helps during pandemic

Micro Focus Recognized as a Leader in IT and Enterprise Service Management by Research in Action (RIA)
04/05/2020 3:00pm
PR Newswire (US)

Micro Focus (LSE:MCRO)
Intraday Stock Chart

Monday 4 May 2020

Click Here for more Micro Focus Charts.
SANTA CLARA, Calif., May 4, 2020 /PRNewswire/ -- Micro Focus (LSE: MCRO; NYSE: MFGP) today announced that Service Management Automation X (SMAX) has been recognized as a Market Leader in the Research in Action (RIA) Vendor Selection Matrix™: IT and Enterprise Management, March 2020. Further strengthening its place as a trusted ESM solution, Micro Focus SMAX was also recently cited as a Major Player in the IDC MarketScape: ITSM 2020 Vendor Assessmenti, as well as a Leader in The Forrester Wave™: Enterprise Service Management, Q4 2019.

Telit Launches CBRS-Only Version of the World's First mPCIe Gigabit LTE Data Card
27/04/2020 2:00pm
PR Newswire (US)

Telit Communications (LSE:TCM)
Intraday Stock Chart

Monday 27 April 2020

Click Here for more Telit Communications Charts.
LONDON, April 27, 2020 /PRNewswire/ -- Telit, a global enabler of the Internet of Things (IoT), today announced that its LM960A PCI Express Mini Card (mPCIe) family is now available in a version supporting the Citizens Broadband Radio Service (CBRS) to serve a broad range of applications that can benefit from private networking, such as, but not limited to, warehousing, industrial manufacturing, public and enterprise venues. The new CBRS-specific module is the latest example of Telit's leadership in providing the CBRS market with LTE-Advanced high-performance solutions to foster the deployment of IoT devices on private LTE CBRS networks. The new cost-optimized module is hardware and software compatible with the LM960A18. With full industrial temperature range, it is ideal for high data rate applications, including industrial gateways, enterprise routers and CPEs, high resolution video cameras and bandwidth intensive industrial sensors like infrared, x-ray and ultrasound imagers. For more information about Telit's mobile broadband modules and data cards, visit https://www.telit.com/m2m-iot-products/cellular-modules/data-cards/.

why is some i d i o t selling 6000 shares ..only comes to 150.00

mm playing games
cant buy but can sell

wood group down 24 per cent!!

Israeli scientists: 'In three weeks, we will have coronavirus vaccine'
“Congratulations to MIGAL on this exciting breakthrough."